SWM
RPTX

Spire Wealth Management’s Repare Therapeutics RPTX Stock Holding History

Spire Wealth Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$11K – 2818
2021
Q4 		$11K Buy
+500
New +$11.8K ﹤0.01% 2354
2021
Q2 		– Sell
-1,000
Closed -$28K – 2907
2021
Q1 		$28K Buy
+1,000
New +$34K ﹤0.01% 2005

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Spire Wealth Management's RPTX Position: Q1 2022 in Review

Spire Wealth Management sold out of Repare Therapeutics (RPTX) in Q1 2022, closing a stake of 500 shares — an estimated $11K sold.

Spire Wealth Management first reported a position in RPTX in Q1 2021 and held it in 2 quarters. The position peaked at $28K in Q1 2021. 62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Spire Wealth Management reported no remaining Repare Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Spire Wealth Management sold 500 Repare Therapeutics shares in Q1 2022, an estimated $11K.
  • Spire Wealth Management first reported a position in Repare Therapeutics in Q1 2021 and held it in 2 quarters.
  • Spire Wealth Management's Repare Therapeutics position peaked at $28K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.